June 4, 2014

David Stastny summarized the "seven deadly sins" that cause reduced purchase prices or failed M&A exits:

  • Inability to prove business synergies and other ways of scaring the buyers away
  • Failure to leverage intellectual property or flawed IP
  • Unresolved potential litigation
  • Discrepancies in financial, accounting or operational planning
  • Contract mistakes, omissions or non-transferability
  • Sloppy corporate governance
  • HR & employee snafus

Watch this webinar to learn how to discover, isolate and correct these "seven deadly sins," whether you are currently developing your M&A exit strategy, or you just want to be prepared!

Request the Recording
of the Webinar




ShareVault’s secure document sharing solution gives pharmaceutical and biotechnology  organizations the confidence to simply and securely share sensitive documents with third parties during due diligence, product development, technology transfers, fundraising, partnering, collaborative research and other activities that require the highest level of document security.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.